Soolantra cream contains ivermectin, which acts on inflammatory pathways and Demodex mites associated with papulopustular rosacea. It is intended for adults with facial rosacea involving inflammatory bumps and pustules. Daily topical use can reduce lesions and help the skin look calmer over time.
Soolantra is a topical ivermectin cream for adult facial rosacea. Ivermectin belongs to the avermectin class and has antiparasitic and anti-inflammatory activity. The product is supplied as a cream in a 45 g tube.
Soolantra is a topical ivermectin cream for adult facial rosacea. Ivermectin belongs to the avermectin class and has antiparasitic and anti-inflammatory activity. The product is supplied as a cream in a 45 g tube.
Papulopustular rosacea produces red or inflamed bumps, pustules, flushing, and persistent facial redness. Soolantra is used for the inflammatory lesions rather than as a general moisturiser or cosmetic cream. Its action may involve reducing Demodex mite activity on the skin and lowering inflammatory signalling within rosacea-prone areas [1].
The cream is intended for cutaneous use. It should stay away from the eyes, lips, and inside of the nose.
Use Soolantra on the affected facial areas once daily, following the individual treatment plan prescribed for you. The amount per application is set individually rather than being one fixed amount for every person.
The cream is for external use only. Do not apply it to the scalp, chest, or other body sites unless those areas have been specifically included in the treatment plan.
If a daily application is missed, apply the next scheduled amount when remembered. Do not apply extra cream to compensate for the missed application. Applying more than directed may increase irritation without producing faster improvement.
Rosacea often improves gradually. In clinical trials, inflammatory lesion counts were assessed over several weeks, so early mild redness or stinging does not automatically mean that treatment has failed. A persistent worsening pattern, marked swelling, or a blistering rash requires prompt medical review.
Ivermectin acts on ligand-gated chloride channels in invertebrate nerve and muscle cells. This can immobilise and eliminate susceptible Demodex mites. The medicine also appears to reduce inflammatory processes that contribute to rosacea papules and pustules.
Demodex mites are microscopic organisms found in facial hair follicles. They can be present without symptoms, yet increased mite density and mite-related inflammation may contribute to rosacea in some adults. Soolantra addresses this possible component while also calming inflammatory lesions.
The treatment differs from topical antibiotics. Metronidazole is mainly used for its anti-inflammatory effect, whereas ivermectin combines anti-inflammatory activity with activity against Demodex mites. The choice depends on the lesion pattern, previous treatments, skin sensitivity, and the clinician’s assessment.
Papulopustular rosacea produces red or inflamed bumps, pustules, flushing, and persistent facial redness. Soolantra is used for the inflammatory lesions rather than as a general moisturiser or cosmetic cream.
The following comparison uses treatment categories and active substances rather than commercial brands.
| Treatment approach | Main pharmacological focus | Practical limitation |
|---|---|---|
| Topical ivermectin | Anti-inflammatory activity and reduction of Demodex mite activity | May cause early irritation, burning, or dryness |
| Topical metronidazole | Anti-inflammatory treatment for papules and pustules | Does not provide the same recognised anti-Demodex action |
| Topical azelaic acid | Anti-inflammatory and keratinisation-modifying activity | Can sting or burn, especially on sensitive skin |
Soolantra may suit adults whose rosacea includes papules and pustules, especially when Demodex-related inflammation is considered relevant. Metronidazole may be selected when a person has previously responded to it or needs a different topical anti-inflammatory approach. Azelaic acid can be useful when inflammatory lesions occur alongside uneven skin texture, yet stinging can be troublesome for some people.
These treatments are not interchangeable by volume or application schedule. A person should not layer several irritating products over the same area without a clear plan, because combined irritation can resemble worsening rosacea.
Soolantra is not suitable for you if you have previously experienced a serious allergic reaction to ivermectin or any ingredient in the cream. A history of severe medicine-related facial swelling or breathing difficulty requires special caution.
Use requires specific medical consideration in the following situations:
Systemic absorption from topical ivermectin is expected to be low when it is used as directed, but pregnancy and breastfeeding decisions still require an individual risk assessment. Soolantra should not be applied to the breasts before breastfeeding because an infant could ingest the cream through skin contact.
No major routine interaction is expected from topical ivermectin when it is applied correctly. The practical interaction concern is additive skin irritation from retinoids, benzoyl peroxide, exfoliating acids, strong cleansers, or other topical medicines. Medsafe medicine information describes the product’s local precautions and use in adults [2].
This treatment may not be right for you if you have ever had a serious allergy to ivermectin or another ingredient in the cream. Speak with a clinician before use if you are pregnant, breastfeeding, have damaged or infected facial skin, significant eye symptoms, or use several products that cause burning or peeling. Do not put it on the breasts before breastfeeding, and do not use it on areas beyond the face unless a clinician has included them in your plan.
The most common reactions are local skin effects. These may include burning, stinging, itching, dryness, irritation, redness, or worsening of rosacea symptoms during the early treatment period. The FDA prescribing information describes these reactions as generally local and usually manageable, though treatment may need reassessment when symptoms are intense [1].
Soolantra can also cause eye irritation if it spreads from the face into the eyes. Accidental eye exposure should be managed by rinsing the eyes thoroughly with clean water. Persistent eye pain, marked light sensitivity, blurred vision, or swelling needs urgent medical attention because rosacea itself can involve the eyes.
Practical ways to reduce irritation include:
One detail patients often miss is that a new burning sensation may come from a cleanser, exfoliant, aftershave, or cosmetic product introduced at the same time as Soolantra. Keeping the rest of the routine simple makes the cause easier to identify.
Another useful distinction is between mild initial irritation and an allergic reaction. Facial swelling, hives, widespread rash, wheezing, or difficulty breathing requires immediate medical care and stopping further exposure until evaluated.
Several habits can reduce tolerability or make the treatment appear less useful:
A common practical error is changing cleanser, moisturiser, sunscreen, and treatment during the same week. If irritation appears, the person cannot tell which product caused it. One stable, gentle skincare routine gives a clearer picture.
Do not use leftover topical antibiotics, steroid creams, or acne treatments on the same facial areas without medical direction. Some may worsen rosacea, thin the skin, or increase irritation.
In clinical practice, doctors usually set expectations around lesion control rather than instant removal of redness. Ivermectin cream is aimed at inflammatory bumps and pustules, while persistent flushing and visible facial blood vessels may require a different treatment approach.
A dermatologist will often ask about triggers such as heat, alcohol, spicy food, emotional stress, hot drinks, and irritating skincare products. These factors can continue to provoke flushing even when inflammatory lesions are responding to Soolantra.
Consistency matters because irregular application makes it difficult to judge whether the medicine is working. Doctors also look for signs that a supposed rosacea flare is actually contact dermatitis, acne, perioral dermatitis, seborrhoeic dermatitis, or an eye-related rosacea complication.
Patients should report severe swelling, crusting, blistering, eye pain, visual symptoms, or a rapidly spreading rash. These findings do not fit the usual mild adjustment reaction and need clinical assessment.
Heat, strenuous exercise, hot drinks, alcohol, spicy food, emotional stress, and ultraviolet exposure can trigger rosacea flushing in susceptible adults. The American Academy of Dermatology has described trigger tracking as a useful way to identify personal patterns, while clinical rosacea guidance published before 2026 supports a gentle skincare routine alongside topical treatment. Exercise does not need to stop, but cooler environments, lower-intensity intervals, and gradual cooling may reduce heat-related flares. Soolantra treats inflammatory lesions; it cannot prevent every trigger-related episode. A dated trigger diary can help the American Academy of Dermatology guidance inform individual skincare decisions.
Pregnancy and breastfeeding require an individual assessment because human safety data for topical ivermectin are limited. The FDA prescribing information and Medsafe medicine information advise caution around pregnancy and lactation, with exposure to the infant avoided during breastfeeding. Soolantra should not be applied to the breast before a feed because direct ingestion could occur. The treatment plan should account for pregnancy stage, breastfeeding status, disease severity, and available alternatives. The FDA label was issued in 2014, and Medsafe published its topical ivermectin medicine information in 2023.
Topical ivermectin is not expected to impair concentration or motor coordination when used on the skin as directed. The EMA’s medicine-safety framework distinguishes local topical reactions from medicines that commonly cause sedation or dizziness, and no routine driving restriction is associated with Soolantra. Severe eye irritation or blurred vision would make driving and machinery work unsafe until vision returns to normal. Stop the activity if symptoms interfere with sight or comfort. The FDA label from 2014 does not list a routine driving restriction for topical Soolantra.
Soolantra contains ivermectin and combines anti-inflammatory activity with action against Demodex mites, while topical metronidazole is used mainly for its anti-inflammatory effect. A 2014 randomised study of ivermectin cream published in Dermatology and Therapy reported improvement in inflammatory rosacea lesions, supporting its role in papulopustular disease [3]. Metronidazole may remain suitable for some adults based on prior response, tolerance, and lesion pattern. A clinician can select one approach or adjust treatment when irritation or inadequate control occurs.
A serious previous allergic reaction to ivermectin or an ingredient in the cream rules out further use unless a specialist gives a different plan. Severe facial swelling, widespread hives, breathing difficulty, or a rapidly spreading rash requires urgent medical attention. Eye pain, visual change, or marked light sensitivity also needs prompt assessment rather than continued self-treatment. The product is intended for adult facial rosacea, so unexplained facial eruptions require diagnosis before treatment is continued. The FDA prescribing information from 2014 supports confirming the diagnosis before continuing treatment.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
The bumps around my cheeks became less frequent after the first month. The cream stung for a few minutes at the start, so I stopped using my scrub and changed to a plain moisturiser. My flushing was still present, but the texture improved.
I found the application easy and did not have much dryness. The first two weeks were uneven, with a couple of worse-looking mornings. By the later weeks there were fewer pustules, although hot weather still triggered redness.
The treatment helped the raised spots near my nose, but I became itchy when I used it after a fragranced cleanser. Removing that cleanser settled the irritation. I had expected the background redness to disappear, which did not happen.
My skin felt calmer after several weeks and makeup sat better over the cheeks. I needed to avoid putting it too close to my eyelids because that area watered. The improvement was gradual rather than dramatic.
I noticed fewer inflamed bumps after maintaining the routine for a while. Sunscreen and cold-weather protection still mattered because wind and sun brought back the flush. The cream was manageable once I stopped changing products every few days.
